Ivabradine, also known as the brand name drug Procorlan which is marketed by Servier, recently received a fast track from the FDA for the treatment of chronic heart failure. As an efficacious drug which inhibits the IF current in the sinoatrial node, Ivabradine has proven to be a virtuous symptomatic treatment for chronic stable angina[…]
Fast Track Designation for Chronic Heart Failure Drug Ivabradine
Cardiovascular Agent, Drug Research & Development API Tags: chronic heart failureWorld Health Organization May 05, 2014
New Guidelines Highlight Divalproex Sodium as an Effective Migraine Treatment
Anti-Migraine, Patent Expiration 2018 Tags: migraine headachesWorld Health Organization May 20, 2013
The latest news regarding divalproex sodium is exciting for patients who suffer from migraine headaches. A new set of guidelines were published in the April 24, 2012 issue of Neurology, and presented at the academy’s annual meeting in New Orleans April 21 to 28, 2013. The new guidelines are composed of information from 29 studies[…]
Migraine Sufferers Find Relief with Eletriptan Hydrobromide
Anti-Migraine, Drug Research & Development API, Patent Expiration 2016 Tags: migrainesPfizerWorld Health Organization Jan 09, 2013
Eletriptan Hydrobromide, CAS number 143322-58-1, is a medication indicated for the acute treatment of migraine with or without aura in adults. Known as Relpax, which is marketed by Pfizer, the patent expiration for Eletriptan Hydrobromide is on December 26, 2016 (Patent Use Code U – 876 – TREATMENT OF MIGRAINE WITH OR WITHOUT AURA). Available in[…]
